Colon & Rectal Surgery · Waterville, ME
NPI
1184648784
Since 2006
Specialty
Colon & Rectal Surgery
Code 208C00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
13 Railroad Sq, Suite 1
Waterville, ME, 04901
Phone (207) 877-9562
Groups this clinician bills Medicare through
Medicare paid, 2024
$230K
4,625 services
Medicare patients, 2024
760
Average age 73
Drug cost, 2024
$10.2M
4,489 prescriptions
Company payments, 2025
$5,010
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jerald E Hurdle was code 17003 (destruction skin lesion), 1,289 times for 234 patients. In total Jerald E Hurdle billed 4,625 services in 108 codes, and Medicare paid $230K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-10-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,289 | 234 | $4.30 | $5,549 |
| 99213 Office E&M - Established | Office | 838 | 549 | $55.79 | $47K |
| 11102 Skin Biopsy | Office | 404 | 337 | $59.74 | $24K |
| 17000 Destruction Skin Lesion | Office | 399 | 309 | $34.10 | $14K |
| 11103 Skin Biopsy | Office | 184 | 126 | $33.51 | $6,165 |
| 99203 Office E&M - New | Office | 177 | 177 | $65.51 | $12K |
| 17110 Destruction Skin Lesion | Office | 96 | 75 | $64.67 | $6,208 |
| 99212 Office E&M - Established | Office | 79 | 49 | $36.24 | $2,863 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 71 | 26 | $0.69 | $48.65 |
| 99214 Office E&M - Established | Office | 70 | 57 | $72.48 | $5,074 |
| 17004 Destruction Skin Lesion | Office | 69 | 63 | $109.18 | $7,533 |
| 12032 Wound Repair - All Levels | Office | 41 | 37 | $188.45 | $7,726 |
| 96372 Injection Administration | Office | 41 | 13 | $10.01 | $410 |
| 11602 Skin Lesion Excision | Office | 27 | 20 | $92.67 | $2,502 |
| 11900 Skin | Office | 26 | 23 | $25.75 | $669 |
By year: 2022 $239K for 4,850 services; 2023 $230K for 5,160 services; 2024 $230K for 4,625 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jerald E Hurdle prescribed most often to Medicare patients was Dupixent Pen (Dupilumab), with 597 prescriptions and refills. In total Jerald E Hurdle wrote 4,489 Medicare prescriptions that cost $10.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dupixent Pen Dupilumab | 597 | 608 | 81 | $2.2M |
| Ketoconazole Generic | 287 | 311 | 129 | $4,420 |
| Triamcinolone Acetonide Generic | 236 | 342 | 135 | $3,427 |
| Clobetasol Propionate Generic | 185 | 206 | 110 | $11K |
| Minocycline Hcl Generic | 178 | 283 | 64 | $3,736 |
| Methotrexate Methotrexate Sodium | 162 | 282 | 45 | $2,510 |
| Humira(Cf) Pen Adalimumab | 162 | 164 | 23 | $1.7M |
| Tacrolimus Generic | 161 | 190 | 88 | $26K |
| Cosentyx Sensoready (2 Pens) Secukinumab | 97 | 97 | Under 11 | $740K |
| Cephalexin Generic | 97 | 97 | 77 | $758 |
| Hydroxyzine Pamoate Generic | 94 | 168 | 33 | $601 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 94 | 98 | 66 | $1,517 |
| Rinvoq Upadacitinib | 89 | 91 | 17 | $580K |
| Fluorouracil Generic | 85 | 87 | 75 | $6,095 |
| Otezla Apremilast | 83 | 83 | 17 | $391K |
Brand drugs: 1,707 claims; generic drugs: 2,782 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jerald E Hurdle $5,010 ($5,010 in general payments such as food, travel and fees) from 16 companies. The largest payer was LEO Pharma Inc. with $1,308.
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 17 | $1,308 |
| Abbvie Inc. ABBV | 59 | $1,138 |
| Galderma Laboratories, L.P. GALD.SW | 46 | $565 |
| Janssen Biotech, Inc. JNJ | 11 | $327 |
| Regeneron Healthcare Solutions, Inc. REGN | 8 | $297 |
| Pfizer Inc. PFE | 27 | $295 |
| UCB, Inc. UCB.BR | 9 | $192 |
| Lilly USA, LLC LLY | 13 | $165 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $153 |
| Incyte Corporation INCY | 6 | $133 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.